These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Yin D; Valles FE; Fiandaca MS; Bringas J; Gimenez F; Berger MS; Forsayeth J; Bankiewicz KS Neuroimage; 2011 Jan; 54 Suppl 1():S196-203. PubMed ID: 19761848 [TBL] [Abstract][Full Text] [Related]
66. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Saito R; Bringas JR; McKnight TR; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS Cancer Res; 2004 Apr; 64(7):2572-9. PubMed ID: 15059914 [TBL] [Abstract][Full Text] [Related]
67. Future of convection-enhanced delivery in the treatment of brain tumors. Bidros DS; Liu JK; Vogelbaum MA Future Oncol; 2010 Jan; 6(1):117-25. PubMed ID: 20021213 [TBL] [Abstract][Full Text] [Related]
70. Poor drug distribution as a possible explanation for the results of the PRECISE trial. Sampson JH; Archer G; Pedain C; Wembacher-Schröder E; Westphal M; Kunwar S; Vogelbaum MA; Coan A; Herndon JE; Raghavan R; Brady ML; Reardon DA; Friedman AH; Friedman HS; Rodríguez-Ponce MI; Chang SM; Mittermeyer S; Croteau D; Puri RK; J Neurosurg; 2010 Aug; 113(2):301-9. PubMed ID: 20020841 [TBL] [Abstract][Full Text] [Related]
71. Intratumoral microinfusion of nimustine (ACNU) for recurrent glioma. Wakabayashi T; Yoshida J; Mizuno M; Kajita Y Brain Tumor Pathol; 2001; 18(1):23-8. PubMed ID: 11517970 [TBL] [Abstract][Full Text] [Related]
72. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma]. Miyagami M; Tazoe M; Kasahara E; Tsubokawa T Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268 [TBL] [Abstract][Full Text] [Related]
76. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas. Saito R; Tominaga T Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285 [TBL] [Abstract][Full Text] [Related]
77. Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery. Rechberger JS; Power EA; Lu VM; Zhang L; Sarkaria JN; Daniels DJ Neurosurg Focus; 2020 Jan; 48(1):E2. PubMed ID: 31896090 [TBL] [Abstract][Full Text] [Related]
78. The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma. Luther N; Zhou Z; Zanzonico P; Cheung NK; Humm J; Edgar MA; Souweidane MM Neuro Oncol; 2014 Jun; 16(6):800-6. PubMed ID: 24526309 [TBL] [Abstract][Full Text] [Related]
79. [Intrathecal ACNU for the treatment of a meningeal gliomatosis model]. Yoshida T; Shimizu K; Mogami H; Egawa T; Sakamoto Y Gan To Kagaku Ryoho; 1987 Jan; 14(1):84-90. PubMed ID: 3467657 [TBL] [Abstract][Full Text] [Related]
80. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report. Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]